Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-7,350
Closed -$773K 103
2019
Q2
$773K Hold
7,350
0.02% 75
2019
Q1
$777K Sell
7,350
-1,966
-21% -$197K 0.02% 62
2018
Q4
$780K Sell
9,316
-100
-1% -$9.05K 0.02% 74
2018
Q3
$960K Sell
9,416
-1,151
-11% -$111K 0.03% 55
2018
Q2
$855K Hold
10,567
0.03% 64
2018
Q1
$753K Sell
10,567
-3,871
-27% -$290K 0.04% 59
2017
Q4
$1.02M Sell
14,438
-541
-4% -$39K 0.04% 52
2017
Q3
$936K Sell
14,979
-1,526
-9% -$90.4K 0.04% 51
2017
Q2
$947K Sell
16,505
-130
-0.8% -$7.65K 0.05% 53
2017
Q1
$952K Sell
16,635
-294,442
-95% -$16.7M 0.06% 50
2016
Q4
$17.1M Sell
311,077
-638,579
-67% -$30.6M 1.02% 19
2016
Q3
$44.6M Sell
949,656
-258,407
-21% -$10.9M 2.66% 12
2016
Q2
$41.1M Buy
+1,208,063
New +$37.7M 1.86% 14

Other funds holding NGVT

Ruffer LLP's NGVT Position: Q3 2019 in Review

Ruffer LLP sold out of Ingevity (NGVT) in Q3 2019, closing a stake of 7,350 shares — an estimated $773K sold.

Ruffer LLP first reported a position in NGVT in Q2 2016 and held it in 13 quarters. The position peaked at $44.6M in Q3 2016. 335 funds tracked by Wall St. Rank hold NGVT as of Q3 2019.

  • Ruffer LLP reported no remaining Ingevity position as of Q3 2019 after selling out during the quarter.
  • Ruffer LLP sold 7,350 Ingevity shares in Q3 2019, an estimated $773K.
  • Ruffer LLP first reported a position in Ingevity in Q2 2016 and held it in 13 quarters.
  • Ruffer LLP's Ingevity position peaked at $44.6M in Q3 2016.
  • 335 funds tracked by Wall St. Rank held Ingevity as of Q3 2019.

Based on Ruffer LLP's 13F filing for Q3 2019, filed 8 Nov 2019.